Cresco Labs Celebrates New Sunnyside Dispensary Opening in South Orlando, Florida

Cresco Labs (CSE:CL) (OTCQX:CRLBF) ("Cresco" or "the Company), a vertically integrated multistate cannabis operator and the No. 1 U.S. wholesaler of branded products, today announced it opened its fourth Sunnyside dispensary in the greater Orlando, Florida region. Sunnyside South Orlando is located at 2051 Town Center Blvd. The new store is the Company's 26 th dispensary in the state and 61 st nationwide.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230302005356/en/

Cresco Labs opened its newest Florida dispensary in South Orlando. (Photo: Business Wire)

Cresco Labs opened its newest Florida dispensary in South Orlando. (Photo: Business Wire)

"We're opening new retail stores in prime locations to sufficiently cover greater Orlando's four corners and serve the needs of the growing patient population in this Florida region," said Charles Bachtell, Cresco Labs' CEO & Co-Founder. "Orlando is home to over 2.5 million residents and attracts over 75 million visitors annually. In addition to our Fern Park, West Orlando and Winter Park locations, we look forward to serving the patient community out of our newest store in South Orlando."

Sunnyside South Orlando is located directly off Highway 441 near major shopping centers. This location will offer a wide assortment of cannabis products from the Company's branded portfolio that includes Cresco, One Plant, Supply (High Supply), Good News, Remedi and Sunnyside. The store also has a curated selection of accessories.

Patients can place orders today both in store and online through the retailer's Sunnyside.shop website. Store hours are Monday through Saturday, 9 AM to 8 PM, and Sunday, 9 AM to 6 PM.

Cresco operates 26 Sunnyside stores in Florida: Avon Park, Bonita Springs, Boynton Beach, Cape Coral, Clearwater, Daytona Beach, Fort Lauderdale, Jacksonville Beach, Lady Lake, Lutz, North Miami, Ocala, Oakland Park, Orlando (Fern Park, West Orlando, South Orlando), Panama City Beach, Pensacola (9 th Ave. and Nine Mile Rd.), Port St. Lucie, Sarasota, St. Petersburg, Tallahassee, Tampa, West Palm Beach and Winter Park.

For more information, visit www.Sunnyside.shop .

About Cresco Labs

Cresco Labs is one of the largest vertically integrated multistate cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Employing a consumer-packaged goods ("CPG") approach, Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands are designed to meet the needs of all consumer segments and comprised of some of the most recognized and trusted national brands including Cresco, High Supply, Mindy's Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Sunnyside, Cresco Labs' national dispensary brand, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco Labs operates the industry's largest Social Equity and Educational Development initiative, SEED, which was established to ensure that all members of society have the skills, knowledge and opportunity to work and own businesses in the cannabis industry. Learn more about Cresco Labs at www.crescolabs.com

Facebook: Cresco Labs

Twitter: Cresco Labs

LinkedIn: Cresco Labs

Media:
Jason Erkes, Cresco Labs
Chief Communications Officer
press@crescolabs.com

Investors:
Megan Kulick, Cresco Labs
Senior Vice President, Investor Relations
investors@crescolabs.com

For general Cresco Labs inquiries:
312-929-0993
info@crescolabs.com

News Provided by Business Wire via QuoteMedia

CL:CNX,CRLBF
The Conversation (0)
Cannabis business with marijuana leaves and stock

Cannabis Market 2025 Year-End Review

2025 marked a turning point for investment in the cannabis sector, shifting the focus toward operational resilience and consolidation after a sluggish 2024. Key market drivers included an upswing in merger and acquisition (M&A) activity as stronger multi-state operators (MSOs) acquired... Keep Reading...
Cannabis plant with green leaves and buds on a dark green background.

Cannabis Market Forecast: Top Trends for Cannabis in 2026

The US cannabis market is entering 2026 with brighter prospects after a punishing few years marked by stalled rescheduling efforts, price compression, retail saturation and slow state expansion.Now, however, regulatory tailwinds seeming aligned for a potential re-rating.On December 18, US... Keep Reading...
Cannabis plant in focus, blurred US flag background.

Analysts React: Trump Signs Executive Order to Reschedule Cannabis

The long-debated issue of US cannabis rescheduling is finally back in the spotlight. On Thursday (December 18), President Donald Trump signed an executive order to expedite the process of moving cannabis from Schedule I to Schedule III under the Controlled Substances Act. Market watchers are now... Keep Reading...
Close-up of green cannabis leaves in natural light.

Trump Weighs Executive Order to Loosen Federal Cannabis Restrictions

US President Donald Trump is reportedly weighing a major shift in federal drug policy that would relax decades-old restrictions on cannabis, potentially injecting new life into the industry. Six people familiar with the discussions told the Washington Post that Trump is preparing an executive... Keep Reading...
Gavel on a surface with scattered cannabis leaves, symbolizing legal issues around marijuana.

Hemp THC Recriminalization: A Blow to a Blooming Industry

A spending bill to reopen the US government after a 43 day shutdown includes provisions that will recriminalize most hemp-derived THC products. This change, slated to become effective one year after enactment, in late 2026, marks a significant policy reversal from the 2018 Farm Bill, which... Keep Reading...
Cannabis buds on a wooden surface with Australian banknotes nearby.

Australia's Cannabis Import Quota Slashed Amid Surging Local Production

Australia’s Office of Drug Control (ODC) said the country’s 2025 cannabis import quota has been reduced by the International Narcotics Control Board from 101 tonnes to 88 tonnes, Business of Cannabis reported.Over-projected demand and idle permits that limited operational flexibility were cited... Keep Reading...

Interactive Chart

Latest Press Releases

Related News